Triazolo[4,5-D]pyramidine derivatives and their use as purine receptor antagonists
US8450328B2 · kind B2 · utility
13Cited by
12References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 25, 2009 |
| Grant date | May 28, 2013 |
| Priority date | — |
| Expiry date | Jul 30, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I) that are capable of acting as purine receptor antagonists, pharmaceutical compositions including the compounds, and methods of making the compounds, are disclosed. The compounds and compositions can be used in treating or preventing disorders related to purine receptor hyperfunctioning.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.